13F HOLDINGS REPORT
SILVERARC CAPITAL MANAGEMENT, LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001420506-23-001081
Total Value
$242.3M
Positions
72
Other Managers
1
Confidential Omitted
No
Holdings (72)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Merus NV | N5749R100 | 668,784 | $12.3M | 5.08% |
| 2 | MacroGenics Inc | MGNX | 1,361,809 | $9.8M | 4.03% |
| 3 | Viewray Inc | 92672L107 | 2,793,748 | $9.7M | 3.99% |
| 4 | Poseida Therapeutics Inc | 73730P108 | 2,689,301 | $8.3M | 3.42% |
| 5 | Oric Pharmaceuticals Inc | ORIC | 1,435,945 | $8.2M | 3.38% |
| 6 | Terns Pharmaceuticals Inc | TERN | 667,922 | $7.9M | 3.26% |
| 7 | Akero Therapeutics Inc | 00973Y108 | 202,561 | $7.7M | 3.20% |
| 8 | Nuvalent Inc | NUVL | 281,533 | $7.3M | 3.03% |
| 9 | Bellus Health Inc | 07987C204 | 1,000,000 | $7.2M | 2.97% |
| 10 | Intra-Cellular Therapies Inc | 46116X101 | 125,035 | $6.8M | 2.79% |
| 11 | 89bio Inc | 282559103 | 438,215 | $6.7M | 2.75% |
| 12 | Viking Therapeutics Inc | VKTX | 380,000 | $6.3M | 2.61% |
| 13 | Cogent Biosciences Inc | COGT | 579,264 | $6.3M | 2.58% |
| 14 | Karyopharm Therapeutics Inc | KPTI | 1,541,426 | $6.0M | 2.48% |
| 15 | KalVista Pharmaceuticals Inc | KALV | 723,544 | $5.7M | 2.35% |
| 16 | Schrodinger Inc | SDGR | 212,825 | $5.6M | 2.31% |
| 17 | Pliant Therapeutics, Inc | PLRX | 199,600 | $5.3M | 2.19% |
| 18 | Aclaris Therapeutics, Inc | ACRS | 651,400 | $5.3M | 2.18% |
| 19 | Gilead Sciences Inc | GILD | 60,130 | $5.0M | 2.06% |
| 20 | BioCryst Pharmaceuticals Inc | BCRX | 577,757 | $4.8M | 1.99% |
| 21 | Veracyte Inc | VCYT | 209,653 | $4.7M | 1.93% |
| 22 | Pharvaris NV | PHVS | 559,387 | $4.5M | 1.86% |
| 23 | ImmunoGen, Inc | 45253H101 | 1,128,200 | $4.3M | 1.79% |
| 24 | United Therapeutics Corp | UTHR | 18,578 | $4.2M | 1.72% |
| 25 | Vertex Pharmaceuticals Inc | VRTX | 13,181 | $4.2M | 1.71% |
| 26 | Regeneron Pharmaceuticals Inc | REGN | 5,000 | $4.1M | 1.70% |
| 27 | Xenon Pharmaceuticals Inc | XENE | 96,643 | $3.5M | 1.43% |
| 28 | Cerus Corp | CERS | 1,152,902 | $3.4M | 1.41% |
| 29 | Biogen Idec Inc | BIIB | 11,311 | $3.1M | 1.30% |
| 30 | 89bio, Inc | 282559103 | 200,000 | $3.0M | 1.26% |
| 31 | Celldex Therapeutics Inc | CLDX | 84,651 | $3.0M | 1.26% |
| 32 | Alnylam Pharmaceuticals Inc | ALNY | 14,043 | $2.8M | 1.16% |
| 33 | Krystal Biotech Inc | KRYS | 34,014 | $2.7M | 1.12% |
| 34 | Cullinan Oncology Inc | CGEM | 265,032 | $2.7M | 1.12% |
| 35 | Pliant Therapeutics Inc | PLRX | 100,000 | $2.7M | 1.10% |
| 36 | Mirum Pharmaceuticals Inc | MIRM | 105,939 | $2.5M | 1.05% |
| 37 | Incyte Corp | INCY | 33,938 | $2.5M | 1.01% |
| 38 | Insmed Inc | INSM | 143,794 | $2.5M | 1.01% |
| 39 | Protagonist Therapeutics Inc | PTGX | 105,486 | $2.4M | 1.00% |
| 40 | Madrigal Pharmaceuticals Inc | MDGL | 10,000 | $2.4M | 1.00% |
| 41 | Ventyx Biosciences Inc | 92332V107 | 70,000 | $2.3M | 0.97% |
| 42 | MoonLake Immunotherapeutics | MLTX | 105,750 | $2.3M | 0.93% |
| 43 | Mersana Therapeutics Inc | 59045L106 | 540,059 | $2.2M | 0.92% |
| 44 | Immatics Nv | IMTX | 282,432 | $1.9M | 0.80% |
| 45 | Morphic Holding Inc | 61775R105 | 51,684 | $1.9M | 0.80% |
| 46 | Aclaris Therapeutics Inc | ACRS | 220,100 | $1.8M | 0.74% |
| 47 | Altimmune, Inc | ALT | 415,700 | $1.8M | 0.72% |
| 48 | Trevi Therapeutics Inc | TRVI | 885,924 | $1.6M | 0.68% |
| 49 | Prometheus Biosciences Inc | 74349U108 | 13,921 | $1.5M | 0.62% |
| 50 | Point Biopharma Global Inc | 730541109 | 198,477 | $1.4M | 0.60% |
| 51 | Phathom Pharmaceuticals Inc | PHAT | 200,000 | $1.4M | 0.59% |
| 52 | Intellia Therapeutics Inc | NTLA | 37,858 | $1.4M | 0.58% |
| 53 | Eliem Therapeutics Inc | CLYM | 485,955 | $1.4M | 0.58% |
| 54 | Seres Therapeutics Inc | MCRB | 232,525 | $1.3M | 0.54% |
| 55 | Sarepta Therapeutics Inc | SRPT | 9,270 | $1.3M | 0.53% |
| 56 | Astria Therapeutics Inc | 04635X102 | 93,823 | $1.2M | 0.52% |
| 57 | Cue Biopharma Inc | CUE | 306,278 | $1.1M | 0.45% |
| 58 | Allakos Inc | 01671P100 | 211,010 | $938,995 | 0.39% |
| 59 | Viridian Therapeutics Inc | VRDN | 36,381 | $925,533 | 0.38% |
| 60 | Jasper Therapeutics Inc | JSPRW | 500,000 | $905,000 | 0.37% |
| 61 | Bridgebio Pharma Inc | BBIO | 40,000 | $663,200 | 0.27% |
| 62 | Acumen Pharmaceuticals Inc | ABOS | 146,922 | $596,503 | 0.25% |
| 63 | ImmunoGen Inc | 45253H101 | 150,000 | $576,000 | 0.24% |
| 64 | Tela Bio Inc | TELA | 54,096 | $575,581 | 0.24% |
| 65 | Aligos Therapeutics Inc | ALGS | 631,887 | $552,269 | 0.23% |
| 66 | Cvrx Inc | CVRX | 30,000 | $279,600 | 0.12% |
| 67 | Monte Rosa Therapeutics Inc | GLUE | 31,156 | $242,705 | 0.10% |
| 68 | LAVA Therapeutics NV | N51517105 | 140,291 | $232,883 | 0.10% |
| 69 | Compugen Ltd | CGEN | 330,188 | $231,792 | 0.10% |
| 70 | Eloxx Pharmaceuticals Inc | ELOX | 54,075 | $135,728 | 0.06% |
| 71 | Rocket Pharmaceuticals Inc | RCKTW | 104,828 | $11,531 | 0.00% |
| 72 | Fresh Tracks Therapeutics Inc | 10802T204 | 10,000 | $6,600 | 0.00% |